Seemingly in one of the first decisions overseen by the company’s new CEO Richard Francis, Teva will not sit at the table of the US brand industry trade association, the Pharmaceutical Research and Manufacturers of America, better known as PhRMA.
With an entrenched hybrid business model and novel assets in its pipeline, Teva has called time on its membership with the powerful US brand industry trade association, the Pharmaceutical Research and Manufacturers of America, or PhRMA, after six-and-a-half years.
Teva’s decision comes weeks after the company’s new CEO, Richard Francis, suggested the potential for clarity on the firm’s long-term...
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
